A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants

NCT05827874 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Nipocalimab
BIOLOGICAL: Tdap
BIOLOGICAL: PPSV23

Sponsor

Janssen Research & Development, LLC